On top of this, our regression analyses adding the VEGFB adipose expression to models only utilizing serum TGs as an explanatory variable for NAFLD imply that VEGFB expression captures components of the NAFLD variance that are not captured by TGs alone. Here, VEGFB is linked to metabolic dysfunction-associated steatotic liver disease.